Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain?
about
The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitorsOld age and male sex are associated with increased risk of asymptomatic erosive esophagitis: analysis of data from local health examinations by the Korean National Health Insurance Corporation.Calcium channel blockers and esophageal sclerosis: should we expect exacerbation of interstitial lung disease?An investigation into drug-related problems identifiable by commercial medication review software.Evaluation and management of patients with noncardiac chest pain.Non-prescription proton-pump inhibitors for self-treating frequent heartburn:the role of the Canadian pharmacist.Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distressManagement of noncardiac chest pain in women.Optimal management of digital ulcers in systemic sclerosisReducing fall risk while managing pain and insomnia: Addressing polypharmacy in an 81-year-old womanThe clinical significance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with Jackhammer esophagus versus Nutcracker esophagus.Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy.Relationship between atrial fibrillation and gastroesophageal reflux disease: a multicenter questionnaire survey.
P2860
Q26866168-C28EC9F7-7E9C-4AFE-9EDC-967A24F398F1Q33813924-8BF52606-1E3C-4448-AC17-DFC005A8240AQ35831217-06935E4D-238D-44D7-98BF-2EB22CD874ACQ36832393-398EA799-DC4E-47BF-8CB8-D17C45F6A9A6Q37458198-91ED73A9-23BC-4820-8CE2-913490497CEAQ37532133-9D70961B-C9A1-4772-98CD-D2C90595C456Q37572542-178778D0-7AFA-41BF-9380-CD75C5DC510BQ37989175-E1103AE4-1463-4CB5-BCBD-2FF2A1C79A3AQ38537531-BA16B330-4394-4AE9-AA71-452B0A27347FQ42094275-31A95DE4-7490-4E19-834E-61AF72788BB4Q48019993-2CE56935-7EE2-4971-8A94-6FC11BAB4271Q48455012-7814784C-97EB-4A29-BE53-12771295C5C8Q51404085-4F80E670-99ED-439E-840E-AE12CE9FC220
P2860
Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@ast
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@en
type
label
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@ast
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@en
prefLabel
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@ast
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@en
P2093
P2860
P1476
Do calcium antagonists contrib ...... omitant noncardiac chest pain?
@en
P2093
Andrew Joyce
Jeff Hughes
Judith Lockhart
P2860
P356
10.1111/J.1365-2125.2007.02851.X
P407
P577
2007-02-12T00:00:00Z